Cannabis stocks are finishing 2020 on a high; Cann Group, Bod announce new European orders

Cannabis stocks aren’t finished in 2020 just yet, continuing to report news as the year winds down.

2020 has been a positive year for the cannabis sector with several regulatory milestones achieved, including in Australia.

Cannabis stocks on the ASX have reflected on the consequent improved sentiment, up 34 per cent in 2020 even taking into account the impact of the COVID-19 induced market crash in the March quarter.

Here’s a list of all ASX cannabis stocks and their performance in 2020

Code	Company	Price	%Mth	%Yr	MktCap
WOA	Wide Open Agriculture	0.92	-12	581	$83.7M
DTZ	Dotz Nano Ltd	0.24	0	314	$90.3M
IHL	Incannex Healthcare	0.15	30	150	$149.8M
LSH	Lifespot Health Ltd	0.08	-13	135	$10.8M
NTI	Neurotech Intl	0.033	14	106	$19.9M
APH	AP Hemp Ltd	0.33	16	83	$19.3M
EVE	EVE Investments Ltd	0.009	-10	80	$38.4M
CPH	Creso Pharma Ltd	0.205	541	71	$134.0M
ZLD	Zelira Therapeutics	0.094	38	69	$106.7M
BDA	Bod Australia	0.46	-12	56	$46.0M
CP1	Cannpal Animal	0.17	26	55	$15.4M
SCU	Stemcell United Ltd	0.018	13	50	$12.4M
ESE	Esense-Lab Ltd	0.018	0	50	$9.2M
BOT	Botanix Pharma Ltd	0.125	9	49	$121.6M
IDT	IDT Australia Ltd	0.165	-13	27	$40.5M
AGH	Althea Group	0.42	-14	18	$105.2M
CAN	Cann Group Ltd	0.54	74	15	$133.6M
LV1	Live Verdure Ltd	0.19	0	0	$7.4M
LGP	Little Green Pharma	0.53	25	0	$41.4M
ECS	ECS Botanics Holding	0.042	62	-7	$17.9M
RNO	Rhinomed Ltd	0.17	-8	-13	$44.4M
MMJ	MMJ Group Hlds Ltd	0.125	4	-14	$27.6M
AC8	Auscann Grp Hlgs Ltd	0.195	50	-15	$52.3M
MXC	Mgc Pharmaceuticals	0.026	24	-16	$41.7M
MDC	Medlab Clinical Ltd	0.25	32	-23	$69.9M
EOF	Ecofibre Limited	1.92	17	-30	$281.7M
PAL	Palla Pharma Ltd	0.77	-4	-30	$96.4M
THC	THC Global Grp Ltd	0.25	11	-32	$44.6M
ROO	Roots Sustainable	0.02	0	-33	$10.7M
SUD	Suda Pharmaceuticals	0.036	-8	-34	$11.1M
CAU	Cronos Australia	0.13	60	-40	$6.1M
YPB	YPB Group Ltd	0.0025	0	-50	$10.6M
RGI	Roto-Gro Intl Ltd	0.058	45	-52	$12.8M
CGB	Cann Global Limited	0.0065	30	-54	$35.6M
MRG	Murray River Grp	0.009	-10	-60	$19.9M
EXL	Elixinol Global	0.195	15	-61	$43.4M
EN1	Engage:Bdr Limited	0.006	-25	-74	$14.2M

More orders from Europe

The good news has kept rolling in this morning for a couple of ASX cannabis stocks which are involved in the European market.

One is Cann Group (ASX:CAN) which announced the initial order of its medical cannabis oil had just completed shipment to the UK.

Cann is the exclusive supplier to local company LYPHE and LYPHE will utilise Cann’s products as part of participation in Project Twenty21 – Europe’s largest medicinal cannabis recruitment registry. Project Twenty21 provides access to cannabis but also gathers data on treatment efficacy.

Cann says its products will be available to UK doctors to prescribe from next week.

The other cannabis stock with order news was Bod Australia (ASX:BDA). It’s secured $871,413 in binding purchase orders from Italy of its hemp seed oil-based gel product.

This order is additional to the initial $1 million order Bod received only a month ago from Italy and will be sold by Health & Happiness Group (HKSE:1112) across 4,000 pharmacies across Italy.

Bod CEO Jo Patterson said it was pleasing to see positive momentum in such a short space of time.

“We expect additional purchase orders to continue to grow in size and volume,” she said.

Are shares getting high?

Cann Group shares rose by 12 per cent while Bod shares rose by 12 per cent this morning.

Bod is in the top 10 cannabis stocks for 2020 gains, having risen over 50 per cent.

Cann Group meanwhile is in negative territory for 2020 after a massive drop during March’s crash but shares have been gradually rising again since securing debt finance with NAB.